The latest closing stock price for Relmada Therapeutics as of November 22, 2024 is 2.80.
An investor who bought $1,000 worth of Relmada Therapeutics stock at the IPO in 2019 would have $-751 today, roughly -1 times their original investment - a -24.28% compound annual growth rate over 5 years.
The all-time high Relmada Therapeutics stock closing price was 50.12 on February 26, 2020.
The Relmada Therapeutics 52-week high stock price is 7.22, which is 157.9% above the current share price.
The Relmada Therapeutics 52-week low stock price is 1.88, which is 32.9% below the current share price.
The average Relmada Therapeutics stock price for the last 52 weeks is 3.69.
An investor who bought $1,000 worth of Relmada Therapeutics stock at the IPO in 2019 would have $-751 today, roughly -1 times their original investment - a -24.28% compound annual growth rate over 5 years.
The all-time high Relmada Therapeutics stock closing price was 50.12 on February 26, 2020.
The Relmada Therapeutics 52-week high stock price is 7.22, which is 157.9% above the current share price.
The Relmada Therapeutics 52-week low stock price is 1.88, which is 32.9% below the current share price.
The average Relmada Therapeutics stock price for the last 52 weeks is 3.69.